BioSig Increases Case Volume Estimates
01 nov. 2021 12h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias
12 oct. 2021 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiovascular Electrophysiology
04 oct. 2021 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal...
BioSig Selects Plexus Corp. as its Manufacturing Partner
28 sept. 2021 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
21 sept. 2021 10h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Gastroesophageal Reflux Disease (GERD) Treatment Devices Markets, 2018-2020 & 2021-2026
14 sept. 2021 04h08 HE
|
Research and Markets
Dublin, Sept. 14, 2021 (GLOBE NEWSWIRE) -- The "Gastroesophageal Reflux Disease (GERD) Treatment Devices - Market Insights, Competitive Landscape and Market Forecast - 2026" report has been added to...
BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System
13 sept. 2021 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium
31 août 2021 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium
19 août 2021 11h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Outlook on the Anti-Snoring Treatment Global Market to 2027 - Technological Advancements in Anti-Snoring Devices Presents Opportunities
13 août 2021 07h53 HE
|
Research and Markets
Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Anti-Snoring Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to...